Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

L-arginine for Prevention of Kidney Damage in Liver Transplant Recipients

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
W. Ray Kim, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00587418
First received: December 21, 2007
Last updated: August 30, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)